BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Clin Cases. Jun 6, 2026; 14(16): 120945
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.120945
Table 2 Details regarding seizure, antiseizure medication, and baseline vitamin D level
Characteristics
Values [mean ± SD or median (IQR)]
Values, n (%)
Age at onset of seizure (year)6.5 ± 3.9-
Duration of seizure prior to start of ASM (month)1 (0-6)-
Duration of ASM (month)4.3 ± 1.1-
Baseline vitamin D [25(OH)D] level (ng/mL) in different treatment groups
Monotherapy21.84 ± 10.161 (40.7)
Polytherapy20.12 ± 9.389 (59.3)
Enzyme-inducing ASM119.97 ± 9.662 (41.3)
Non-enzyme-inducing ASM221.15 ± 9.888 (58.7)


Write to the Help Desk